Results

Total Results: 2,432 records

Showing results for "risk".

21. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 15, 2002 - In PHS, aspirin reduced the relative risk for myocardial infarction for patients aged 70 to 84 years … Relative risks were 0.75 for patients aged 50 to 59 years and 0.61 for patients aged 60 to 64 years. … In PHS, patients who were taking aspirin and had SBP greater than 150 mm Hg had a relative risk of 0.65 … for myocardial infarction, compared with relative risks of 0.55 for those with SBP between 130 and 149 … The summary relative risk for hemorrhagic stroke with aspirin use was 1.84 (95 percent CI, 1.24 to 2.74

22. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer--brca-testing-ovarian-cancer-screeni
    September 15, 2005 - risks for breast and ovarian cancer in moderate- and high-risk groups. … All chemoprevention trials reported relative risk (RR) estimates, and the logarithm of the RR (logRR) … Sampling Distribution for Relative Risk When developing the outcomes table, the estimates of relative … Risk (95% CI) Type Treat- ment Group,  n Placebo Group, n Relative Risk … Relative Risks for Breast Cancer in Chemoprevention Trials Error bars represent 95% CIs.

23. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - risks for breast and ovarian cancer in moderate- and high-risk groups. … All chemoprevention trials reported relative risk (RR) estimates, and the logarithm of the RR (logRR) … Sampling Distribution for Relative Risk When developing the outcomes table, the estimates of relative … Risk (95% CI) Type Treat- ment Group,  n Placebo Group, n Relative Risk … Relative Risks for Breast Cancer in Chemoprevention Trials

24. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - Age In PHS, aspirin reduced the relative risk for myocardial infarction for patients aged 70 to 84 years … Relative risks were 0.75 for patients aged 50 to 59 years and 0.61 for patients aged 60 to 64 years. … In PHS, patients who were taking aspirin and had SBP greater than 150 mm Hg had a relative risk of 0.65 … for myocardial infarction, compared with relative risks of 0.55 for those with SBP between 130 and … The summary relative risk for hemorrhagic stroke with aspirin use was 1.84 (95% CI, 1.24 to 2.74).

25. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
    September 15, 2013 - that treatment with tamoxifen or raloxifene can significantly reduce the relative risk (RR) for invasive … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative … Breast Cancer Prevention Trial; IBC = invasive breast cancer; WHI = Women's Health Initiative; RR = relative

26. Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer
    April 11, 2016 - outcome, we calculated a range of expected event rates after aspirin intervention using the pooled relative … events will vary depending on individual baseline bleeding risks. … why persons with these risks have been excluded from trials. … Level † Baseline Risk for Outcome, events per 1000 person-years Relative Risk (95% CI) Events … ¶ Using cohort baseline risk and trial relative risks to estimate events caused or prevented.

27. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - outcome, we calculated a range of expected event rates after aspirin intervention using the pooled relative … events will vary depending on individual baseline bleeding risks. … why persons with these risks have been excluded from trials. … Level † Baseline Risk for Outcome, events per 1000 person-years Relative Risk (95% CI) Events … ¶ Using cohort baseline risk and trial relative risks to estimate events caused or prevented.

28. Tagauj5Qoarfv3M8Fapbon (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TAgAUJ5QoaRfV3M8fApBoN
    June 03, 2019 - below 1 after 16 or more years of follow-up (relative risk, 0.79). … The relative risks by year of observation (including trial plus follow-up time) are shown in the Figure … Both of these trials reported relative risk re- ductions among women 65 to 74 years of age (relative … (50), 1997 No 5 Swedish trials Weighted relative risks 12.8 0.77 (0.59–1.01) Nyström et al. (32), … Relative risk was calculated as exp(�).

29. Screening for Ovarian Cancer: Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
    July 01, 1994 - Using the relative risks reported by Kerlikowske and colleagues (16), we can estimate that a family … Calculated from relative risk estimates and ovarian cancer incidence data from the SEER (Surveillance … associated with contraceptive pill use; both found similar relative risks of approximately 0.65 associated … ; both studies found a relative risk of approximately 0.5 after 5 years of use. 3.11 Parity has also … 50% (that is, a relative risk of 0.5) for any pregnancy, with decreasing risk associated with an increasing

30. Final Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
    September 26, 2024 - disease risk assessment without these risk markers? … What are other risk markers used in enhanced cardiovascular disease risk assessment and what is their … How do 10-year risk scores compare between the two models? … integrated discrimination improvement), calibration (e.g., agreement between observed and predicted risks … ), and decision curve analysis KQs 3, 5: Serious adverse events from risk factor assessment or risk

31. Draft Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
    April 25, 2024 - multivariate cardiovascular disease risk assessment without these risk markers? … What are other risk markers used in enhanced cardiovascular disease risk assessment and what is their … assessment: Base model risk assessment (e.g., PREVENT, PCE, FRS) + CAC score Base model risk assessment … integrated discrimination improvement), calibration (e.g., agreement between observed and predicted risks … ), and decision curve analysis KQs 3, 5: Serious adverse events from risk factor assessment or risk

32. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - outcome, we calcu- lated a range of expected event rates after aspirin in- tervention using the pooled relative … Baseline Estimates of Major Bleeding Risks (Trial vs. … Risk for Outcome, events per 1000 person-years Relative Risk (95% CI) Events Caused per 1000 Person-Years … as reported by included cohort studies. ¶ Using cohort baseline risk and trial relative risks to estimate … why persons with these risks have been excluded from trials.

33. Archived: Evidence Summary: Breast Cancer: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-screening-2002
    September 03, 2002 - Data Synthesis: For studies of fair quality or better, the summary relative risk was 0.84 (95% CrI, … follow-up (relative risk, 0.79). … The relative risks by year of observation (including trial plus follow-up time) are shown in the Figure … Both of these trials reported relative risk reductions among women 65 to 74 years of age (relative risk … Relative risk was calculated as exp(β).

34. Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling
    February 03, 2014 - For all cases, we analyzed unadjusted relative risks based on the number of events and nonevents. … The pooled unadjusted relative risk was 0.98 (95% CI, 0.91 to 1.04). … RR = relative risk. Return to Table of Contents Figure 2. … RR = relative risk. Return to Table of Contents Figure 3. … RR = relative risk. Return to Table of Contents Appendix Table 1.

35. Archived: Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-february-2014
    February 03, 2014 - For all cases, we analyzed unadjusted relative risks based on the number of events and nonevents. … The pooled unadjusted relative risk was 0.98 (95% CI, 0.91 to 1.04). … RR = relative risk. Return to Table of Contents Figure 2. … RR = relative risk. Return to Table of Contents Figure 3. … RR = relative risk. Return to Table of Contents Appendix Table 1.

36. Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/uPbfDukSXmFDWq8FDwTgKj
    July 03, 2018 - Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors … Clinical Summary: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors Population … Grade: I (insufficient evidence) Risk Assessment Several traditional risk factors are associated … Risk factors can be combined in many w ays to classify a person's risk for a CVD event. … CVD risk assessment in the United States has been generally based on the Framingham Risk Score and the

37. Screening for Postmenopausal Osteoporosis: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
    September 01, 2002 - density testing to identify fracture risks, effectiveness of treatment in reducing fracture risk, and … This was comparable to the magnitude of the relative risks of most of the other significant predictors … 3,723 participants (dosage 10 to 40 mg/d; weighted relative risk, 0.51; CI, 0.38-0.69). … by 70% (relative risk, 1.7). … risk for hip fracture 0.63 0.63 0.63 0.63 0.63 0.63 with treatment Relative risk for vertebral 0.52

38. Recommendation: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
    September 19, 2024 - Share to WhatsApp Share to Email Print Enhanced Risk … See Current Final Recommendation Statement for Cardiovascular Disease: Risk Assessment With Nontraditional … Risk Factors(2018) Final Research Plan Supporting Evidence Related Resources & Tools

39. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 28, 2021 - Aspirin use was significantly associated with lower risk of preeclampsia (pooled relative risk [RR], … Pooled estimates of the relative risks of health outcomes associated with aspirin use were generated … .12), or fetal intracranial bleeding (P = .34), and the relative risks in the increased-risk population … , No. of studies (No. analyzed) a Pooled RR,  random-effects model (95% CI) b I 2 , % τ 2 Relative … risk, range ARD Relative risk, median (IQR) ARD (range) Perinatal mortality 15 (15,527

40. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - Risk for breast cancer. … Risk for adverse effects. … The relative risk reduction for breast cancer was 0.94 (95 percent CI, 0.59-1.43) for the Royal Marsden … significant difference in incidence between the tamoxifen and placebo groups in this age group. 7 The relative … Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.